118 related articles for article (PubMed ID: 3003221)
1. Characterization of pro-opiomelanocortin-derived peptides in pituitary and ectopic adrenocorticotrophin-secreting tumours.
Hale AC; Besser GM; Rees LH
J Endocrinol; 1986 Jan; 108(1):49-56. PubMed ID: 3003221
[TBL] [Abstract][Full Text] [Related]
2. Pro-opiocortin related peptides in human pituitary and ectopic ACTH secreting tumours.
Ratter SJ; Gillies G; Hope J; Hale AC; Grossman A; Gaillard R; Cook D; Edwards CR; Rees LH
Clin Endocrinol (Oxf); 1983 Mar; 18(3):211-8. PubMed ID: 6305538
[TBL] [Abstract][Full Text] [Related]
3. Gamma-melanotrophin-like immunoreactivities in human pituitaries, ACTH-producing pituitary adenomas, and ectopic ACTH-producing tumours: evidence for an abnormality in glycosylation in ectopic ACTH-producing tumours.
Tanaka I; Nakai Y; Nakao K; Oki S; Fukata J; Imura H
Clin Endocrinol (Oxf); 1981 Oct; 15(4):353-61. PubMed ID: 6274545
[TBL] [Abstract][Full Text] [Related]
4. A case of pituitary dependent Cushing's disease with clinical and biochemical features of the ectopic ACTH syndrome.
Hale AC; Millar JB; Ratter SJ; Pickard JD; Doniach I; Rees LH
Clin Endocrinol (Oxf); 1985 Apr; 22(4):479-88. PubMed ID: 2985302
[TBL] [Abstract][Full Text] [Related]
5. Chromatographic characteristics of pro-opiomelanocortin-derived peptides from the rat transplantable tumour 7315a.
Morano MI; Estivariz FE
J Endocrinol; 1987 Mar; 112(3):417-25. PubMed ID: 3031191
[TBL] [Abstract][Full Text] [Related]
6. Alpha-amidated peptides derived from pro-opiomelanocortin in human pituitary tumours.
Fenger M; Johnsen AH
J Endocrinol; 1988 Aug; 118(2):329-38. PubMed ID: 2844950
[TBL] [Abstract][Full Text] [Related]
7. ACTH LPH and related peptides in the ectopic ACTH syndrome.
Pullan PT; Clement-Jones V; Corder R; Lowry PJ; Besser GM; Rees LH
Clin Endocrinol (Oxf); 1980 Nov; 13(5):437-45. PubMed ID: 6261991
[TBL] [Abstract][Full Text] [Related]
8. Corticotrophin-like intermediary lobe peptide as a marker of alternate pro-opiomelanocortin processing in ACTH-producing non-pituitary tumours.
Vieau D; Massias JF; Girard F; Luton JP; Bertagna X
Clin Endocrinol (Oxf); 1989 Dec; 31(6):691-700. PubMed ID: 2560687
[TBL] [Abstract][Full Text] [Related]
9. Development of a radioimmunoassay for an amino-terminal peptide of pro-opiocortin containing the gamma-MSH region: measurement and characterization in human plasma.
Hope J; Ratter SJ; Estivariz FE; McLoughlin L; Lowry PJ
Clin Endocrinol (Oxf); 1981 Sep; 15(3):221-7. PubMed ID: 6273026
[TBL] [Abstract][Full Text] [Related]
10. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses.
Wilson MG; Nicholson WE; Holscher MA; Sherrell BJ; Mount CD; Orth DN
Endocrinology; 1982 Mar; 110(3):941-54. PubMed ID: 6276164
[TBL] [Abstract][Full Text] [Related]
11. Urinary molecular forms of human N-terminal of proopiomelanocortin: possible deglycosylation and degradation by the kidney.
Gaspar L; Chan JS; Seidah NG; Chrétien M
J Clin Endocrinol Metab; 1984 Oct; 59(4):614-21. PubMed ID: 6480799
[TBL] [Abstract][Full Text] [Related]
12. Direct measurement of the precursors of adrenocorticotropin in human plasma by two-site immunoradiometric assay.
Crosby SR; Stewart MF; Ratcliffe JG; White A
J Clin Endocrinol Metab; 1988 Dec; 67(6):1272-7. PubMed ID: 2848055
[TBL] [Abstract][Full Text] [Related]
13. Alpha-amidated peptides derived from pro-opiomelanocortin in normal human pituitary.
Fenger M; Johnsen AH
Biochem J; 1988 Mar; 250(3):781-8. PubMed ID: 2839146
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical evidence for the presence of gamma 1-MSH-like immunoreactivity in pituitary corticotrophs and ACTH-producing tumours.
Ali-Rachedi A; Ferri GL; Varndell IM; Van Noorden S; Schot LP; Ling N; Bloom SR; Polak JM
Neuroendocrinology; 1983 Dec; 37(6):427-33. PubMed ID: 6318146
[TBL] [Abstract][Full Text] [Related]
15. Expression of the neuroendocrine cell marker 7B2 in human ACTH secreting tumours.
Vieau D; Linard CG; Mbikay M; Lenne F; Chretien M; Luton JP; Bertagna X
Clin Endocrinol (Oxf); 1992 Jun; 36(6):597-603. PubMed ID: 1424185
[TBL] [Abstract][Full Text] [Related]
16. Peptides related to the N-terminus of pro-opiomelanocortin in the human adrenal medulla.
Gaspar L; Chan JS; Seidah NG; Chrétien M
Clin Invest Med; 1989 Apr; 12(2):90-8. PubMed ID: 2539931
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical study of 18 tumours causing ectopic Cushing's syndrome.
Coates PJ; Doniach I; Howlett TA; Rees LH; Besser GM
J Clin Pathol; 1986 Sep; 39(9):955-60. PubMed ID: 3020095
[TBL] [Abstract][Full Text] [Related]
18. A new generation IRMA for ACTH with improved specificity: validation in various physiological and pathological conditions.
Guiban D; Massias JF; Dugué MA; Coste J; Bertagna X; Raffin-Sanson ML
Eur J Endocrinol; 2001 Apr; 144(4):369-77. PubMed ID: 11275946
[TBL] [Abstract][Full Text] [Related]
19. Characterization of peptides derived from pro-opiomelanocortin in the biological fluids of a patient with Nelson's syndrome.
Gaspar L; Chan JS; Seidah NG; Chrétien M
Clin Invest Med; 1985; 8(2):167-75. PubMed ID: 3009068
[TBL] [Abstract][Full Text] [Related]
20. Posttranslational processing of proadrenocorticotropin/endorphin-derived peptides during postnatal development in the rat pituitary.
Sato SM; Mains RE
Endocrinology; 1985 Aug; 117(2):773-86. PubMed ID: 2990862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
